CCP
LFMD icon

Clarkston Capital Partners’s LifeMD LFMD Stock Holding History

Clarkston Capital Partners’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,000
Closed -$46K – 194
2022
Q1 		$46K Hold
13,000
– – ﹤0.01% 186
2021
Q4 		$50K Hold
13,000
– – ﹤0.01% 170
2021
Q3 		$81K Sell
13,000
-2,000
-13% -$17.1K ﹤0.01% 154
2021
Q2 		$177K Buy
+15,000
New +$173K ﹤0.01% 146

Other funds holding LFMD

BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIA
Barry Investment Advisors New Bedford, Massachusetts $478M AUM 23.65% 1-Year Est. Return

Clarkston Capital Partners's LFMD Position: Q2 2022 in Review

Clarkston Capital Partners sold out of LifeMD (LFMD) in Q2 2022, closing a stake of 13,000 shares — an estimated $46K sold.

Clarkston Capital Partners first reported a position in LFMD in Q2 2021 and held it in 4 quarters. The position peaked at $177K in Q2 2021. 40 funds tracked by Wall St. Rank hold LFMD as of Q2 2022.

  • Clarkston Capital Partners reported no remaining LifeMD position as of Q2 2022 after selling out during the quarter.
  • Clarkston Capital Partners sold 13,000 LifeMD shares in Q2 2022, an estimated $46K.
  • Clarkston Capital Partners first reported a position in LifeMD in Q2 2021 and held it in 4 quarters.
  • Clarkston Capital Partners's LifeMD position peaked at $177K in Q2 2021.
  • 40 funds tracked by Wall St. Rank held LifeMD as of Q2 2022.

Based on Clarkston Capital Partners's 13F filing for Q2 2022, filed 10 Aug 2022.